Medicom Oncology Clinical Pearls Podcasts
How does the safety profile of the new and emerging anti-PD 1 antibodies differ from chemotherapy?
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:01:55
- Mas informaciones
Informações:
Sinopsis
Listen as Dr. Alison Moskowitz discusses the safety profile of the new and emerging anti-PD1 antibodies and how this differs from traditional chemotherapy in just under two minutes.
